← Back to Search

LumiraDx SARS-CoV-2 & Flu A/B test for COVID-19 (INSPIRE-2 Trial)

N/A

Waitlist Available

Led By Ramin Farsad

Research Sponsored by LumiraDx UK Limited

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 4 months

Awards & highlights

INSPIRE-2 Trial Summary

This trial is testing how well two different point-of-care tests work in detecting SARS-CoV-2, FLU A/B, and RSV in people with symptoms suggestive of these infections.

Eligible Conditions

Flu Type B
COVID-19
Coronavirus
Flu
Respiratory Syncytial Virus

INSPIRE-2 Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 4 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~4 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Performance evaluation by health care professionals

Point of Care usability

INSPIRE-2 Trial Design

2Treatment groups

Experimental Treatment

Group I: Nasopharyngeal SwabExperimental Treatment2 Interventions

Nasopharyngeal swab from subjects with signs and symptoms of COVID-19 and/or Influenza and/or RSV-like illness

Group II: Nasal SwabExperimental Treatment2 Interventions

Nasal swab from subjects with signs and symptoms of COVID-19 and/or Influenza and/or RSV-like illness

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

LumiraDx SARS-CoV-2 & Flu A/B test

2022

N/A

~670

LumiraDx SARS-CoV-2 & RSV test

2022

N/A

~670

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

LumiraDx UK LimitedLead Sponsor

15 Previous Clinical Trials

33,822 Total Patients Enrolled

7 Trials studying COVID-19

9,687 Patients Enrolled for COVID-19

Ramin FarsadPrincipal InvestigatorDiagnamics, Inc

1 Previous Clinical Trials

2,000 Total Patients Enrolled

Sherri CaseyPrincipal InvestigatorBenchmark Research

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many healthcare locations are administering this research in the metropolitan area?

"This investigation is currently enrolling participants from 8 distinct sites, including Middleburg Heights, Covington and Encinitas. To reduce travel burden while taking part in the trial, it is advised to select a location that is proximate to your residence."

Answered by AI

Are enrollment opportunities currently available for participants in this research?

"According to clinicaltrials.gov, this medical study is not recruiting patients at present. Initially posted on April 1st 2022 and last updated on August 16th 2022, it has yet to resume patient recruitment; however, there are 1166 other trials that are currently searching for participants."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19

2022. "Performance Evaluation of the LumiraDx SARS-CoV-2 & FLU A/B and SARS-CoV-2 & RSV Tests for Aid in the Assessment of COVID-19". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05268939.